The University of California at San Francisco Diabetes Center, an organized research unit, has functioned for more than a half-century as a basic and clinical research enterprise at the forefront of diabetes research. Historically, the program has participated in seminar series, supported early stage research, and emphasized a strong basic and clinical research interface. The goal of the Center is to support a highly interactive team investigating Type 1 and Type 2 diabetes to advance the study and treatment of the disease. The Center encompasses a broad range of intellectual and research expertise from 21 departments and organized research units and four UCSF campuses focused on both basic and clinical research. In this application, the UCSF Diabetes Center proposes to renew its Diabetes and Endocrinology Research Center (DERC) grant funding that supports the following activities: An Administrative Core that provides leadership, infrastructure, administrative support, and advice and oversight to the other components and members of the DERC, and interfaces with the NIDDK, other NIH Diabetes Centers, and the lay community. Biomedical Medical Research Cores Islet Metabolism Core Cytometry and Cell Sorting Core Microscopy Core Mouse Genetics Core A Pilot &Feasibility Program that funds small innovative projects that support new investigators, explore novel areas of investigators for established investigators, attract new investigators to the DERC, promote interactions and lead to external support to further the goals of the DERC. An Enrichment Program that furthers the goals of the DERC by enhancing scientific exchange and training with seminar series, invited speakers and an annual retreat.
The support requested in this application will provide the infrastructure, core laboratories, pilot and feasibility grants, and enrichment programs that will accentuate the collaboration and accelerate the progress of 56 principal investigators at UCSF and their associated groups studying diabetes with the goal of advancing the study and treatment of Type 1 and Type 2 diabetes.
|Khan, Imran S; Mouchess, Maria L; Zhu, Meng-Lei et al. (2014) Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. J Exp Med 211:761-8|
|von Figura, Guido; Fukuda, Akihisa; Roy, Nilotpal et al. (2014) The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 16:255-67|
|Schaufele, Fred (2014) Maximizing the quantitative accuracy and reproducibility of Forster resonance energy transfer measurement for screening by high throughput widefield microscopy. Methods 66:188-99|
|Ghosh, Rajarshi; Wang, Likun; Wang, Eric S et al. (2014) Allosteric inhibition of the IRE1? RNase preserves cell viability and function during endoplasmic reticulum stress. Cell 158:534-48|
|Lee, K; Nguyen, V; Lee, K-M et al. (2014) Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy. Am J Transplant 14:27-38|
|Ni, Wei; Watts, Stephanie W; Ng, Michael et al. (2014) Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension 64:1290-8|
|Maly, Dustin J; Papa, Feroz R (2014) Druggable sensors of the unfolded protein response. Nat Chem Biol 10:892-901|
|Kim, Mee J; Oksenberg, Nir; Hoffmann, Thomas J et al. (2014) Functional characterization of SIM1-associated enhancers. Hum Mol Genet 23:1700-8|
|Baeyens, Luc; Lemper, Marie; Leuckx, Gunter et al. (2014) Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat Biotechnol 32:76-83|
|Khan, Imran S; Taniguchi, Ruth T; Fasano, Kayla J et al. (2014) Canonical microRNAs in thymic epithelial cells promote central tolerance. Eur J Immunol 44:1313-9|
Showing the most recent 10 out of 132 publications